{"transactions":[{"id":1177751,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-04T20:12:12.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":65000,"derivative":{"exercise_price":1.07,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000905148-25-001093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000090514825001093/form4.xml","form_type":"4"}},{"id":1572658,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T20:22:03.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":50000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000905148-24-000967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000090514824000967/form4.xml","form_type":"4"}},{"id":1730424,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-24T22:37:11.000Z","date":"2023-11-22","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.035,"value":5175.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."}],"balance_after":11500,"source":{"system":"sec-edgar","filing":"0000905148-23-001527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000090514823001527/form4.xml","form_type":"4"}},{"id":1730423,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-24T22:37:11.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.99,"value":4950.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0000905148-23-001527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000090514823001527/form4.xml","form_type":"4"}},{"id":1941855,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T20:21:02.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control."}],"balance_after":50000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-03-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-23-013072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000114036123013072/form4.xml","form_type":"4"}},{"id":2247795,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":48762,"kind":"person","name":"Burkavage Brian","position":1,"cik":"0001865633","reported_name":"Burkavage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T22:25:10.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control."}],"balance_after":20000,"derivative":{"exercise_price":4.83,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-22-012194","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865633/000156761922012194/doc1.xml","form_type":"4"}}]}